Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heubach is one of the world’s leading manufacturers of organic and inorganic pigments—including anticorrosive types—for use across coatings/paints/plastics/corrosion protection/pharmaceutical coloring/seeds/color printing industries. The group was founded over two centuries ago and has expanded via major acquisitions including DuPont’s pigment unit and most recently integrating Clariant’s global pigment business with support from SK Capital Partners. As of late 2024 it is being acquired by India-based Sudarshan Chemical Industries Ltd., which will create one of the largest global players in industrial colorants. While some products serve pharmaceutical applications as excipients/coloring agents for drugs/tablets/capsules/coatings etc., this is not a life sciences/drug development firm but rather an advanced materials/specialty chemicals manufacturer focused on sustainable innovation within its sector.
No evidence supports any direct involvement with drug discovery/development platforms or therapeutic pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heubach.